CR10106A - - Google Patents

Info

Publication number
CR10106A
CR10106A CR10106A CR10106A CR10106A CR 10106 A CR10106 A CR 10106A CR 10106 A CR10106 A CR 10106A CR 10106 A CR10106 A CR 10106A CR 10106 A CR10106 A CR 10106A
Authority
CR
Costa Rica
Application number
CR10106A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CR10106A publication Critical patent/CR10106A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CR10106A 2005-12-20 2008-06-23 CR10106A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MXPA05014092A MXPA05014092A (es) 2005-12-20 2005-12-20 Composiciones farmaceuticas que comprenden sustancias derivadas de la tiazolidinedionas combinadas con una biguanida para su uso en diabetes mellitus tipo 2.

Publications (1)

Publication Number Publication Date
CR10106A true CR10106A (es) 2008-08-06

Family

ID=38188841

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10106A CR10106A (es) 2005-12-20 2008-06-23

Country Status (6)

Country Link
EP (1) EP1964562A1 (es)
BR (1) BRPI0620103A2 (es)
CR (1) CR10106A (es)
EC (1) ECSP088566A (es)
MX (1) MXPA05014092A (es)
WO (1) WO2007073136A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX339374B (es) * 2011-04-29 2016-05-13 Inst De Investigación En Química Aplic S A De C V Cocristales ionicos con base en metformina.
WO2013095316A1 (en) * 2011-12-19 2013-06-27 Mahmut Bilgic Synergic combination comprising anti-diabetic agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
CA2351058A1 (en) * 1998-11-12 2000-05-25 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
WO2003005995A1 (en) * 2001-07-10 2003-01-23 Aeropharm Technology Incorporated Core formulation comprising pioglitazone hydrochloride and a biguanide
IN192749B (es) * 2002-11-15 2004-05-15 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
ECSP088566A (es) 2008-07-30
MXPA05014092A (es) 2007-06-20
WO2007073136A1 (es) 2007-06-28
BRPI0620103A2 (pt) 2011-11-01
EP1964562A1 (en) 2008-09-03

Similar Documents

Publication Publication Date Title
BRPI0601358B8 (pt) Aplicador de clipe cirúrgico
BRPI0601402B8 (pt) Aplicador de grampos cirúrgicos
BR122017004709A2 (es)
JP2005222687A5 (es)
BRPI0609157A8 (es)
BRPI0608519A2 (es)
JP2005205216A5 (es)
BR122020005056A2 (es)
BR122016029989A2 (es)
BRPI0604219A (es)
BRPI0618215B8 (es)
ECSDI056169S (es)
BY2237U (es)
CN105122969C (es)
CN300725990S (zh) 鞋帮
CN300726002S (zh) 鞋帮
CN300725996S (zh) 鞋帮
CN300725995S (zh) 鞋帮
CN300725994S (zh) 鞋底
CN300726007S (zh) 鞋底
CN300725993S (zh) 鞋帮
CN300725992S (zh) 鞋底
CN300725991S (zh) 鞋帮
CN300726004S (zh) 鞋帮
CN300851460S (zh) 椅子的座位部

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)